Pseudoephedrine/Tecastemizole

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePseudoephedrine/Tecastemizole
Drug Alias NameTecastemizole+PseudoephedrinePseudoephedrine+TecastemizoleTecastemizole/Pseudoephedrine
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsAlpha adrenergic receptor agonists
TargetsHistamine H1 receptorAlpha adrenergic receptor
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A